Cited by 329Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

FSH blockade improves cognition in mice with Alzheimer’s disease

Open access
Xiong, Jing, Kang, Seong Su, Wang, Zhihao, Liu, Xia, Kuo, Tan-Chun, Korkmaz, Funda, Padilla, Ashley, Miyashita, Sari +20 more·2022·Nature

Abstract

Alzheimer's disease has a higher incidence in older women, with a spike in cognitive decline that tracks with visceral adiposity, dysregulated energy homeostasis and bone loss during the menopausal transition 1,2. Inhibiting the action of follicle-stimulating hormone (FSH) reduces body fat, enhances thermogenesis, increases bone mass and lowers serum cholesterol in mice 3-7. Here we show that FSH acts directly on hippocampal and cortical neurons to accelerate amyloid-β and Tau deposition and impair cognition in mice displaying features of Alzheimer's disease. Blocking FSH action in these mice abrogates the Alzheimer's disease-like phenotype by inhibiting the neuronal C/EBPβ-δ-secretase pathway. These data not only suggest a causal role for rising serum FSH levels in the exaggerated Alzheimer's disease pathophysiology during menopause, but also reveal an opportunity for treating Alzheimer's disease, obesity, osteoporosis and dyslipidaemia with a single FSH-blocking agent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-022-04463-0

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated levels of follicle-stimulating hormone directly promote the accumulation of amyloid-β and hyperphosphorylated tau in the hippocampus via the C/EBPβ-δ secretase pathway, leading to neuronal apoptosis, synaptic damage and spatial learning deficits.

    “The elevated level of follicle-stimulating hormone (FSH) directly promotes the accumulation of Aβ and hyperphosphorylated tau in the hippocampus via the C/EBPβ-δ secretase pathway, leading to neuronal apoptosis, synaptic damage and spatial learning deficits.353”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xiong, J., Kang, S. S., Wang, Z., Liu, X., Kuo, T.-C., Korkmaz, F., Padilla, A., Miyashita, S., Chan, P., Zhang, Z., Katsel, P., Burgess, J., Gumerova, A., Ievleva, K., Sant, D., Yu, S.-P., Muradova, V., Frolinger, T., Lizneva, D., Iqbal, J., Goosens, K. A., Gera, S., Rosen, C. J., Haroutunian, V., Ryu, V., Yuen, T., Zaidi, M., & Ye, K.
Affiliations
  • Emory University (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Renmin Hospital of Wuhan University (CN)
  • Maine Medical Center Research Institute (US)
Corresponding author
  • Zaidi, Mone
  • Ye, Keqiang
Venue
Nature
Published
2022-03-02
Volume
603
Issue
7901
Pages
470-476
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4214944386
Cited by
329
References
66
Citations by year
2026: 48 · 2025: 78 · 2024: 89 · 2023: 75 · 2022: 39
FWCI
43.62
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • National Institutes of Health (UL1TR002378)
  • National Institute on Aging (R01AG065177, RF1AG051538, R01AG071870, U19AG060917, U01AG073148, R01AG074092, P30AG066514)
  • National Institute of General Medical Sciences (P20GM121301)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK113627)
  • National Institute of Neurological Disorders and Stroke (P30NS055077)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
follicle-stimulating hormone, Alzheimer's disease, menopause, amyloid-beta deposition, tau deposition, cognitive impairment, hippocampal neurons, cortical neurons, obesity, osteoporosis, dyslipidemia, energy homeostasis
MeSH terms
Aged, Alzheimer Disease, Animals, Cognition, Female, Follicle Stimulating Hormone, Humans, Bone Density, Thermogenesis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review